Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.

Podrobná bibliografie
Hlavní autor: Fairbank, J
Médium: Journal article
Jazyk:English
Vydáno: 2007
_version_ 1826289798258622464
author Fairbank, J
author_facet Fairbank, J
author_sort Fairbank, J
collection OXFORD
description
first_indexed 2024-03-07T02:34:23Z
format Journal article
id oxford-uuid:a84c79b0-d4b8-4d3b-a41d-3c28d5e5ebd6
institution University of Oxford
language English
last_indexed 2024-03-07T02:34:23Z
publishDate 2007
record_format dspace
spelling oxford-uuid:a84c79b0-d4b8-4d3b-a41d-3c28d5e5ebd62022-03-27T03:00:31ZRe: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a84c79b0-d4b8-4d3b-a41d-3c28d5e5ebd6EnglishSymplectic Elements at Oxford2007Fairbank, J
spellingShingle Fairbank, J
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
title Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
title_full Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
title_fullStr Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
title_full_unstemmed Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
title_short Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
title_sort re zigler j delamarter r spivak j et al results of the prospective randomized multicenter food and drug administration investigational device exemption study of the prodisc l total disc replacement versus circumferential fusion for the treatment of 1 level degenerative disc disease spine 2007 32 1155 62
work_keys_str_mv AT fairbankj reziglerjdelamarterrspivakjetalresultsoftheprospectiverandomizedmulticenterfoodanddrugadministrationinvestigationaldeviceexemptionstudyoftheprodiscltotaldiscreplacementversuscircumferentialfusionforthetreatmentof1leveldegenerativediscdiseasespine200732115